Supplement warning: Overdosing on this to lower high blood pressure could be deadly

SUPPLEMENTS popularly used include vitamin C, vitamin D3 and omega-3 - and potassium may also be taken to ward off high blood pressure, heart disease, stroke, arthritis, cancer, digestive disorders, and infertility. However, too much of the mineral could be deadly.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer, Published online: 21 June 2018; doi:10.1038/s41397-018-0030-8Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer
Source: The Pharmacogenomics Journal - Category: Drugs & Pharmacology Authors: Source Type: research
Well-balanced levels of tyrosine phosphorylation, maintained by the reversible and coordinated actions of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs), are critical for a wide range of cellular processes including growth, di fferentiation, metabolism, migration, and survival. Aberrant tyrosine phosphorylation, as a result of a perturbed balance between the activities of PTKs and PTPs, is linked to the pathogenesis of numerous human diseases, including cancer, suggesting that PTPs may be innovative molecular targets for cancer treatment. Two PTPs that have an important inhibitory role in haemato...
Source: Oncology - Category: Cancer & Oncology Source Type: research
The study is potentially a “leap forward” in cancer genomics, particularly for subsets of patients with metastatic and anaplastic thyroid cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
In the Utah Cancer Survivors Study, male thyroid cancer survivors had an almost 50% higher risk of developing cardiovascular disease than females.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
AbstractDespite significant advances in our ability to treat cancer, cytotoxic chemotherapy continues to be the mainstay treatment for many solid tumours. Chemotherapy is commonly associated with a raft of largely manageable adverse events; however, gastrointestinal (GI) toxicity (also termed mucositis) remains a significant challenge with little in the way of preventative and therapeutic options. The inability to manage GI complications likely reflects our incomplete understanding of its aetiology and the idiosyncrasies of each chemotherapeutic agent. This review highlights aims to provide a narrative for the involvement ...
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
Saby George, MD, FACP, Roswell Park Cancer Institute, shares CARMENA Study Results | Sunitinib Not Inferior to Sunitinib Following Nephrectomy at ASCO 2018 Author: Annual-Meeting Added: 06/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
Saby George, MD, FACP, Roswell Park Cancer Institute, explains Checkmate-214 has a Higher Response Rate | 9% of Patients Went on to Complete Response at ASCO 2018 Author: Annual-Meeting Added: 06/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
Conclusions: A majority of ESD for EGC were performed in tertiary care hospitals in Korea. The clinical status showed excellent clinical outcomes and did not differ by the year and between the types of hospitals in Korea. PMID: 29921044 [PubMed - as supplied by publisher]
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Tags: Korean J Intern Med Source Type: research
Funding for research that seeks to identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices into public health, clinical practice, and community settings. This program is featured in the Division of Cancer Control and Population Sciences Selected List of Funding Opportunities Relevant to Rural Cancer Control. Geographic coverage: Nationwide -- National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
Source: Funding opportunities via the Rural Health Information Hub - Category: American Health Source Type: funding
Saby George, MD, FACP, Roswell Park Cancer Institute, explains Update on Checkmate-214 Study | Approval of Nivolumab &Ipilimumab Combination at ASCO 2018 Author: Annual-Meeting Added: 06/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Arthritis | Cancer | Cancer & Oncology | Cardiology | Health | Heart | Heart Disease | Hypertension | Infertility | Omega 3 | Overdose | Potassium | Reproduction Medicine | Rheumatology | Stroke | Vitamin C | Vitamin D3 | Vitamins | Warnings